Consensus Document on Home Nebulization for Maintenance Treatment of Obstructive Airway Diseases: A Joint Initiative by the National Allergy Asthma Bronchitis Institute (NAABI) and Chest Research Foundation (CRF)

J Assoc Physicians India. 2017 May;65(5):60-73.

Abstract

Recent years have seen an increase in the use of nebulizers for delivering maintenance therapy in obstructive airway diseases (OADs) such as asthma and chronic obstructive pulmonary disease (COPD). The probable factors associated with this increase at home are: convenience of drug delivery, technological advances making the nebulizer equipment more efficient and portable, increase in the prevalence of OADs and the ageing population which may impact the optimal use of handheld inhalers such as pressurized metered dose inhalers (pMDIs) and dry powder inhalers (DPIs). Although there is increase in the use of maintenance therapy with nebulization, there has been no such increase in the evidence base available for the appropriate use of nebulizers. The last international guidelines were published in 2001. Hence there is a need to address this knowledge gap especially with the widespread use of home nebulization in India. With this objective, we organized a consensus meeting to address certain critical questions pertaining to the use of nebulizers for maintenance treatment in OADs. This article presents the findings of the consensus panel on the use of maintenance treatment of OADs with nebulization at home.

Publication types

  • Consensus Development Conference
  • Practice Guideline

MeSH terms

  • Administration, Inhalation
  • Bronchodilator Agents / administration & dosage
  • Consensus
  • Expectorants / administration & dosage
  • Humans
  • Lung Diseases, Obstructive / drug therapy*
  • Maintenance Chemotherapy / methods
  • Nebulizers and Vaporizers*
  • Patient Education as Topic
  • Patient Selection*
  • Self Care*

Substances

  • Bronchodilator Agents
  • Expectorants